Inhibitors

SLx-2119; Belumosudil; KD-025; KD025; Rezurock; SLx 2119; 2-[3-[4-(1H-Indazol-5-Ylamino)Quinazolin-2-yl]Phenoxy]-N-Propan-2-Ylacetamide; Acetamide, 2-(3-(4-(1H-Indazol-5-Ylamino)-2-Quinazolinyl)Phenoxy)-N-(1-Methylethyl)-; 2-(3-(4-(1H-Indazol-5-Ylamino)Quinazolin-2-yl)Phenoxy)-N-Isopropylacetamide; 2-[3-[4-(1~{H}-Indazol-5-Ylamino)Quinazolin-2-yl]Phenoxy]-~{N}-Propan-2-yl-Ethanamide; 2-[3-[4-(1H-Indazol-5-Ylamino)-2-Quinazolinyl]Phenoxy]-N-(1-Methylethyl)-Acetamide; 2-(3-{4-[(1H-Indazol-5-yl)Amino]Quinazolin-2-yl}Phenoxy)-N-(Propan-2-yl)Acetamide; 2-[3-[4-(1H-Indazol-5-Ylamino)-2-Quinazolinyl]Phenoxy]-N-(1-Methylethyl)Acetamide

Elacestrant Hydrochloride; RAD1901 Dihydrochloride; RAD1901 Hydrochloride; RAD-1901 Dihydrochloride; Elacestrant (Dihydrochloride); 1349723-93-8 (HCl); (R)-6-(2-(Ethyl(4-(2-(Ethylamino)Ethyl)Benzyl)Amino)-4-Methoxyphenyl)-5,6,7,8-Tetrahydronaphthalen-2-ol Dihydrochloride; Elacestrant 2HCl; 2-Naphthalenol, 6-(2-(Ethyl((4-(2-(Ethylamino)Ethyl)Phenyl)Methyl)Amino)-4-Methoxyphenyl)-5,6,7,8-Tetrahydro-, Hydrochloride (1:2), (6R)-; Elacestrant (RAD1901) Dihydrochloride; (6r)-6-(2-(N-(4-(2-(Ethylamino)Ethyl)Benzyl)-N-Ethylamino)-4-Methoxyphenyl)5,6,7,8-Tetrahydronaphthalen-2-ol Dihydrochloride; (6R)-6-[2-[Ethyl-[[4-[2-(Ethylamino)Ethyl]Phenyl]Methyl]Amino]-4-Methoxyphenyl]-5,6,7,8-Tetrahydronaphthalen-2-ol;Dihydrochloride

Dapagliflozin Propanediol Monohydrate; Dapagliflozin Propanediol Hydrate; Farxiga; Dapagliflozin ((2S)-1,2-Propanediol, Hydrate); Dapagliflozin S-Propylene Glycol Monohydrate; Dapagliflozin Propylene Glycolate Hydrate; (2S,3R,4R,5S,6R)-2-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]-6-(Hydroxymethyl)Oxane-3,4,5-Triol;(2S)-Propane-1,2-diol;Hydrate; Dapagliflozin; Dapagliflozin Propylene Glycol Hydrate; (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-Ethoxybenzyl)Phenyl)-6-(Hydroxymethyl)Tetrahydro-2H-Pyran-3,4,5-Triol Compound WITH (S)-Propane-1,2-DIOL (1:1) Hydrate; Dapagliflozin (S)-Propylene Glycol Hydrate; Dapagliflozin Propylene Glycol; Dapagliflozin (2S)-1,2-Propanediol Hydrate; BMS-512148 (2S)-1,2-Propanediol, Hydrate; Dapagliflozin (2S)-1,2-Propanediol Monohydrate; Xigduo Component Dapagliflozin Propanediol; Dapagliflozin Propanediol Component OF Xigduo; Dapagliflozin Compound WITH (2S)-1,2-Propanediol Hydrate; (2S)-Propane-1,2-diol (2S,3R,4R,5S,6R)-2-{4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl}-6-(Hydroxymethyl)Oxane-3,4,5-Triol Hydrate; (2S)-Propane-1,2-diol--(1S)-1,5-Anhydro-1-[4-Chloro-3-(4-Ethoxybenzyl)Phenyl]-D-Glucitol--Water (1/1/1); (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-Ethoxybenzyl)Phenyl)-6-(Hydroxymethyl)Tetrahydro- 2H-Pyran-3,4,5-Triol, (2S)-Propane-1,2-DIOL (1:1) Monohydrate; (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-Ethoxybenzyl)Phenyl)-6-(Hydroxymethyl)Tetrahydro-2H-Pyran-3,4,5-Triol (S)-Propane-1,2-diol Hydrate; (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-Ethoxybenzyl)Phenyl)-6-(Hydroxymethyl)Tetrahydro-2H-Pyran-3,4,5-Triol, (2S)-Propane-1,2-diol (1:1) Monohydrate

NKTR-118 Oxalate; Naloxegol (Oxalate); AZ13337019 Oxalate; AZ-13337019 Oxalate; Naloxegol Oxalate(NKTR-118); Moventig; (4R,4aS,7S,7aR,12bS)-7-[2-[2-[2-[2-[2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy]Ethoxy]Ethoxy]Ethoxy]Ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-Octahydro-4,12-Methanobenzofuro[3,2-e]Isoquinoline-4a,9-diol;Oxalic acid; Movantik; 4,5Alpha-Epoxy-6Alpha-((3,6,7,12,15,18,21-Heptaoxadocosyl)oxy)-17-(prop-2-enyl)Morphinan-3,14-diol Hydrogen Ethanedioate; 4,5Alpha-Epoxy-6Alpha-[(3,6,7,12,15,18,21-Heptaoxadocosyl)oxy]-17-(prop-2-enyl)Morphinan-3,14-diol Hydrogen Ethanedioate; NKTR-118-Oxalate; NKTR-118;AZ-13337019 Oxalate; Movantik Component Naloxegol Oxalate; Naloxegol Oxalate Component OF Movantik; Morphinan-3,14-DIOL, 4,5-Epoxy-6-(3,6,9,12,15,18,21-Heptaoxadocos-1-Yloxy)-17-(2-Propen-1-YL)-, (5.Alpha.,6.Alpha.)-, Ethanedioate (1:1); Morphinan-3,14-diol, 4,5-Epoxy-6-(3,6,9,12,15,18,21-Heptaoxadocos-1-Yloxy)-17-(2-Propen-1-yl)-, (5Alpha,6Alpha)-, Ethanedioate (1:1)

960539-70-2; GSK1278863; GSK-1278863; Jesduvroq; GSK 1278863; N-((1,3-Dicyclohexylhexahydro-2,4,6-Trioxopyrimidin-5-yl)Carbonyl)Glycine; (1,3-Dicyclohexyl-2,4,6-Trioxohexahydropyrimidine-5-Carbonyl)Glycine; 2-[(1,3-Dicyclohexyl-2,4,6-Trioxo-1,3-Diazinan-5-yl)Formamido]Acetic acid; Glycine, N-((1,3-Dicyclohexylhexahydro-2,4,6-Trioxo-5-Pyrimidinyl)Carbonyl)-; Duvroq; 2-[(1,3-Dicyclohexyl-2,4,6-Trioxo-1,3-Diazinane-5-Carbonyl)Amino]Acetic acid; N-[(1,3-Dicyclohexylhexahydro-2,4,6-Trioxopyrimidin-5-yl)Carbonyl]Glycine; Duvroq (TN); Daprodustat;(1,3-Dicyclohexyl-2,4,6-Trioxohexahydropyrimidine-5-Carbonyl)Glycine